RV to LV Diameter Ratio May Predict Mortality in Interstitial Lung Disease
An increased right to left ventricle diameter ratio may help identify high-risk patients with suspected interstitial lung disease/pulmonary hypertension.
Restrictive Lung Disease
FDA Panel Votes on Nintedanib for Systemic Sclerosis Associated Interstitial Lung Disease
The FDA Arthritis Advisory Committee voted 10 to 7 in favor of approval of Ofev for the treatment of systemic sclerosis associated with interstitial lung disease.
Azathioprine and Mycophenolate Mofetil May Benefit Myositis-Related ILD
In patients with myositis-related interstitial lung disease, azathioprine and mycophenolate mofetil treatment offers clinical improvements and a reduction in prednisone dose.
Specific Variables Improve Disease Severity Discrimination Among CF Transplant Candidates
Including Cystic Fibrosis Foundation Patient Registry variables in the lung allocation score calculation allowed for enhanced discrimination of disease severity and improved access in patients with cystic fibrosis as well as COPD.
No Evidence to Support Use of Omega-3 PUFAs in Bronchopulmonary Dysplasia
Omega-3 long-chain polyunsaturated fatty acids cannot prevent the occurrence of bronchopulmonary dysplasia in preterm infants.
Short-Term Effectiveness of Antifibrotics in Idiopathic Pulmonary Fibrosis
Patients taking the antifibrotic medications nintedanib and pirfenidone for idiopathic pulmonary fibrosis had reduced all-cause mortality and hospitalizations for up to 2 years compared with a matched untreated cohort.
Support for a Calcium-Based Therapeutic Approach in Pulmonary Fibrosis
Use of a calcium-based therapeutic approach may be helpful for the management of an atypical form of pulmonary fibrosis.
Malondialdehyde-Acetaldehyde Antibodies in RA-Interstitial Lung Disease
Researchers conducted both serologic and tissue expression tests which revealed that for rheumatoid arthritis-associated interstitial lung disease immune responses from anti-malondialdehyde acetaldehyde adducts modified proteins may serve as biomarkers.
Prognostic Effects of Imaging Ratios in Idiopathic Pulmonary Fibrosis
Investigators sought to determine a potential link between mPA/Ao ratio at diagnosis and clinical characteristics and outcomes in patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis Outcomes Similar With Pneumonia or Acute Exacerbation
Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with pneumonia and patients with an acute IPF exacerbation.
Next post in ATS 2019 Meeting
